Navigation Links
Auspex Raises $35 Million And Appoints Industry Veteran Gerald Proehl To Its Board of Directors
Date:1/8/2014

LA JOLLA, Calif., Jan. 8, 2014 /PRNewswire/ -- Auspex Pharmaceuticals, Inc., a Phase 3 clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced the completion of two separate financings totaling $35 million and appointment of a new Board member:

  • $20 million Series E equity financing led by Deerfield Management Company and supported by existing investors, Thomas, McNerney and Partners, CMEA Capital, Panorama Capital, BioMed Ventures and Costa Verde Capital; and
  • $15 million, four-year venture loan from Oxford Finance LLC.

"These financings strengthen the balance sheet as we advance SD-809, our lead program, in Phase 3 clinical development for the treatment of chorea associated with Huntington's disease," said Pratik Shah, Ph.D., President and Chief Executive Officer of Auspex. "We believe Auspex is in a strong financial and strategic position to continue developing and seeking to commercialize novel medicines for the treatment of orphan diseases."

"We have been impressed by the quality of the management team, the potential of the SD-809 program for the treatment of hyperkinetic movement disorders and the promise of the deuterium chemistry platform," said Jonathan Leff, Partner at Deerfield Management and Chairman of the Deerfield Institute. "We are pleased to be supporting Auspex as it advances development of SD-809 and other compounds in its pipeline of deuterium-substituted analogues of clinically validated drugs," added William Slattery, Partner at Deerfield Management.

The company also announced the addition of Gerald Proehl, former President and CEO of Santarus, Inc., as a member of the company's Board of D
'/>"/>

SOURCE Auspex Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auspex Initiates Phase 3 Trial of SD-809 in Huntingtons Disease
2. Auspex Pharmaceuticals Receives U.S. Patent on Novel JAK Inhibitor SD-900
3. Bellicum Pharmaceuticals Raises $34.4 Million in a Series B Financing
4. Crescendo Biologics Raises £17.5M ($28M) in Series A Financing
5. Child Mind Institute Raises $6.6 Million at Annual Child Advocacy Award Dinner for the Advancement of Childrens Mental Health and Brain Research
6. Senhwa Biosciences Raises $17M Series B
7. Sitari Pharmaceuticals, First Company Launched Through Avalon Ventures-GlaxoSmithKline Collaboration, Raises up to $10 Million Series A Financing and R&D Support
8. Western Refining Raises $337,000 During Month-long 22nd Annual St. Jude Halloween Promotion
9. Bayers Third Annual Virtual Walk for Hemophilia Raises Funds, Brings Together the Hemophilia Community
10. AMRI Announces Third Quarter 2013 Results and Raises Full Year EPS Guidance
11. arGEN-X raises EUR 5 Million from PMV in Extension of EUR 32.5 Million Series B
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... PLYMOUTH MEETING, Pa. , Dec. 15, 2014 ... ) announced today it has been added to ... the NASDAQ Biotechnology Index will become effective upon ... The NASDAQ Biotechnology Index is designed to track ... that are classified as either biotechnology or pharmaceutical ...
(Date:12/15/2014)... 2014  Stephen Squires, CEO and founder of leading ... (OTCQB:QTMM), will be speaking at the launch event ... December 16th, 2014. The RCQM launch continues Rice University,s ... top faculty and students and by inviting the world,s ... "We have a long association with Rice ...
(Date:12/13/2014)... , Dec. 11, 2014 Research and ... the addition of the "Drug Injection Devices ... http://photos.prnewswire.com/prnh/20130307/600769 ... of an expanding list of health conditions, drug ... that simplify the administration process and increase the ...
Breaking Medicine Technology:Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 2Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 3Inovio Pharmaceuticals Added to NASDAQ Biotechnology Index 4Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4
... March 1, 2011 Syndax Pharmaceuticals, a clinical-stage ... (NCI) will sponsor a multi-center phase 2 study ... of histone deacetylases (HDAC), and anastrozole, an aromatase ... breast cancer to evaluate biomarkers and surrogates for ...
... Conn., March 1, 2011 To kick off ... products and the Colon Cancer Alliance (CCA) have teamed ... the fears of the colonoscopy. Colon cancer is 90 percent ... avoid getting a colonoscopy—the colon cancer screening test that could ...
Cached Medicine Technology:Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer 2Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer 3Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer 4Carmen Marc Valvo, Designer and Cancer Survivor, Teams Up With Dulcolax® and the Colon Cancer Alliance to Make it Fashionable for Americans to Get Screened 2Carmen Marc Valvo, Designer and Cancer Survivor, Teams Up With Dulcolax® and the Colon Cancer Alliance to Make it Fashionable for Americans to Get Screened 3Carmen Marc Valvo, Designer and Cancer Survivor, Teams Up With Dulcolax® and the Colon Cancer Alliance to Make it Fashionable for Americans to Get Screened 4Carmen Marc Valvo, Designer and Cancer Survivor, Teams Up With Dulcolax® and the Colon Cancer Alliance to Make it Fashionable for Americans to Get Screened 5
(Date:12/15/2014)... Grants Pass, OR (PRWEB) December 15, 2014 ... factors perceived by United States women as impacting skin ... – the “Four C’s of skin care.” Water and ... the conclusions in a recent article describing the survey ... her experience, every item in every category discussed would ...
(Date:12/15/2014)... CARSON CITY, NV (PRWEB) December 15, 2014 ... new powerhouse company, JM Ocean Avenue. JM Ocean ... technology of the Veretekk online automated marketing system. ... by the June 2014 merger of Ocean Avenue and ... a more than $2 Billion per year company. , ...
(Date:12/15/2014)... December 15, 2014 South Florida’s leading urgent ... holidays can be a daze of hassle, hustle, and bustle ... while decking halls, to burns when making special meals and ... that can happen at any time. To prevent this season ... has made a list of helpful and healthful holiday tips ...
(Date:12/15/2014)... 15, 2014 OutMarket , a ... “ Social Media Cheat Sheets ,” a guide that ... drives results on the top ten social media networks. ... helps drive awareness, engagement, and customer service. It can ... make an impact on new networks and weather constantly ...
(Date:12/15/2014)... Steven Reinberg HealthDay Reporter ... large, new study should reassure the millions of American women ... for breast cancer. "There is no association between migraine ... associate professor of medicine at Harvard Medical School. "There is ... and there is no protective effect either." About 18 ...
Breaking Medicine News(10 mins):Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2
... University Of Pennsylvania School Of Medicine suggest that the human ... akin to an Ethernet// connection, which is one of the ... a comparison of neural systems with artificial ones, as ... the available information. These findings have been presented in the ...
... study on the Gender Impact of HIV and AIDS in India ... girl child is also the most likely one to be withdrawn// ... with AIDS. The National AIDS Control Organisation (NACO) estimates that women ... in India in 2005. ,This means that women make up 39 ...
... of California, San Diego (UCSD) School of Medicine, the ... created// and tested molecular therapy in animals which they ... sclerosis (ALS), or Lou Gehrig's disease. The study has ... of therapeutic molecules known as antisense oligonucleotides to the ...
... the researchers for US it was found that tomosyn plays ... The protein gets its name from the Japanese language //because ... team. This protein binds to syntaxin another protein which is ... tomosyn, tomo meaning friend in Japanese. Better understanding of the ...
... the researchers at the University of Southampton it was ... child's susceptibility to atherosclerosis. // ,The study analysed ... lower the mother's calorific intake during pregnancy, the thicker ... to measure the thickness of the wall of the ...
... Cedars-Sinai Medical Center this week launched an International Stem ... embryonic stem cell research. // ,The academic medical ... geneticist Nissim Benvenisty, M.D., Ph.D., as the institute’s co-director ... Research and Scientific Affairs at Cedars-Sinai. ,“This ...
Cached Medicine News:Health News:Measuring the Quantity of Information Passed on From the Eye to the Brain 2Health News:Measuring the Quantity of Information Passed on From the Eye to the Brain 3Health News:Molecular Therapy Holds Promise in the Treatment of Amyotrophic Lateral Sclerosis 2Health News:Molecular Therapy Holds Promise in the Treatment of Amyotrophic Lateral Sclerosis 3Health News:Study Shows Tomosyn Plays an Important Role in Learning and Memory 2Health News:Center Launches New International Stem Cell Research Institute 2
... Tip Ureteral Stents combine a unique polymer ... remembering its shape with a chemically bonded ... The result is a stent that satisfies ... patient comfort. Lubri-Flex® is available in a ...
All the advantages of Dr. Roy P. Finney's classic stent design with an open tip....
... ambulatory ECG technology - Until now, if ... Holter on some of your patients while ... the majority of patients, you had to ... Now, all that has changed with Lifecard ...
The Pathfinder HSV 1 and 2 kit provides direct antigen detection and differentiation of Herpes Simplex Virus (HSV) Types 1 and 2. The monoclonal antibody-based test can be used to directly stain cli...
Medicine Products: